ApprovalTrail

Drug · DIN 02138670

REFRESH

Yes: authorized and sold in Canada

Authorized, and the company reports that it sells it in Canada.

Status Marketed since October 16, 2024; first marketed December 31, 1995.
Drug Identification Number (DIN)
02138670
Company (DIN owner)
AbbVie CorporationSaint-Laurent, Quebec, Canada
Schedule
Non-prescription drugs
Dosage form
Drops
Route
Ophthalmic
Therapeutic class (ATC)
Artificial tears and other indifferent preparations. S01XA20
Class
Human
Record last updated
March 22, 2025

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
POLYVINYL ALCOHOL1.4 %W/V

Other DINs named REFRESH